Interferon Alpha Can Delay Full Onset Of Type I Diabetes, Phase II Trial Suggests
Wednesday, July 1, 2009 - 08:35
in Health & Medicine
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to the results of a Phase II trial.
Read the whole article on Science Daily
More from Science Daily
Related
- UT researcher: Interferon alpha can delay full onset of type I diabetesWed, 1 Jul 2009, 9:21:35 EDT
- Fewer injection site reactions in patients using AvonexFri, 11 Sep 2009, 11:43:10 EDT
- New scientific knowledge on juvenile diabetesWed, 17 Dec 2008, 11:37:00 EST
- Diabetes weakens your bonesMon, 28 Sep 2009, 16:08:20 EDT
- Diabetes drug shows potential for treating one cause of chronic kidney diseaseWed, 10 Dec 2008, 17:40:14 EST